Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the STOPSTORM.eu consortium

Strahlenther Onkol. 2024 Apr 23. doi: 10.1007/s00066-024-02230-w. Online ahead of print.

Abstract

This preliminary ethical appraisal from the STOPSTORM.eu consortium is meant to raise critical points that clinicians administering stereotactic arrhythmia radioablation should consider to meet the highest standards in medical ethics and thus promote quality of life of patients recruited for radiotherapy treatments at a stage in which they experience a significant degree of vulnerability.

Keywords: Bioethics; Cardiovascular disease; Ethics in research; Stereotactic Body Radiotherapy; Ventricular tachycardia.